Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange
- PMID: 10349847
- DOI: 10.1046/j.1471-4159.1999.0722379.x
Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange
Abstract
The hypothesis of these studies is that ligand efficacy at the neuronal CB1 receptor is dependent on the ratio of ligand affinities for the active and inactive states of the receptor. Agonist efficacy was determined in rat cerebellar membranes using agonist-induced guanosine 5'-O-(3-[35S]thiotriphosphate) binding; efficacy was variable among the CB1 agonists examined. Ligand affinities for the active and inactive state of the CB1 receptor were determined by competition with [3H]CP55940 and [3H]SR141716A in the presence of 5'-guanylylimidodiphosphate, respectively. All of the agonists investigated had a higher affinity for the active state than the inactive state. The fraction of CB1 receptors in the active state at a maximally effective concentration was calculated for each agonist and was found to correlate significantly with agonist efficacy. These studies demonstrate that the CB1 receptor of the cerebellum can assume an active conformation in the absence of agonist and that the variability in efficacy among CB1 receptor agonists can be explained by the relative affinities of these ligands for the CB1 receptor in the active and inactive states.
Similar articles
-
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.J Pharmacol Exp Ther. 1998 May;285(2):553-60. J Pharmacol Exp Ther. 1998. PMID: 9580597
-
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.Br J Pharmacol. 1999 Feb;126(3):665-72. doi: 10.1038/sj.bjp.0702351. Br J Pharmacol. 1999. PMID: 10188977 Free PMC article.
-
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.Eur J Pharmacol. 1997 Oct 8;336(2-3):295-8. doi: 10.1016/s0014-2999(97)01255-7. Eur J Pharmacol. 1997. PMID: 9384246
-
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.Life Sci. 1999;65(6-7):627-35. doi: 10.1016/s0024-3205(99)00285-4. Life Sci. 1999. PMID: 10462063 Review.
-
Ligand based structural studies of the CB1 cannabinoid receptor.J Pept Res. 2002 Dec;60(6):348-56. doi: 10.1034/j.1399-3011.2002.21069.x. J Pept Res. 2002. PMID: 12464113 Review.
Cited by
-
Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.Biochemistry. 2006 May 2;45(17):5606-17. doi: 10.1021/bi060067k. Biochemistry. 2006. PMID: 16634642 Free PMC article.
-
Endocannabinoid signalling: has it got rhythm?Br J Pharmacol. 2010 Jun;160(3):530-43. doi: 10.1111/j.1476-5381.2010.00790.x. Br J Pharmacol. 2010. PMID: 20590563 Free PMC article. Review.
-
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats.J Psychiatry Neurosci. 2017 Mar;42(2):131-138. doi: 10.1503/jpn.150363. J Psychiatry Neurosci. 2017. PMID: 28245177 Free PMC article.
-
Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Curr Neuropharmacol. 2007;5(2):81-97. doi: 10.2174/157015907780866910. Curr Neuropharmacol. 2007. PMID: 18084639 Free PMC article.
-
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.Br J Pharmacol. 2007 Nov;152(5):691-8. doi: 10.1038/sj.bjp.0707468. Epub 2007 Sep 24. Br J Pharmacol. 2007. PMID: 17891162 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources